Abstract
Background: The standard induction dose (2.5 mgkg−1) of propofol in some patients, especially the elderly can result in cardiopulmonary depression often associated with delayed recovery from anaesthesia. Pretreatment with a small dose of sedative or anaesthetic agent prior to administration of induction agent reduces the dose and adverse effects of the required agent. Objectives: This study compared the effects of midazolam pre-treatment on the induction dose of propofol and aimed to determine the following: (1) The induction dose of propofol in patients with midazolam pre-treatment and those on placebo. (2) The time of induction of anaesthesia using propofol in midazolam pre-treated adults. (3) To compare haemodynamic variations in placebo and midazolam pre-treatment groups. (4) The incidence of complications in both the groups. Materials and Methods: Eighty American Society of Anesthesiologits grade I and II patients aged 18–55 years were enrolled and randomly allocated into two groups (A and B) of 40 each. Two minutes before induction of anaesthesia, group A received 0.02 mgkg−1 of intravenous midazolam whereas group B received equivalent amount of intravenous 0.9% saline. In both the groups, anaesthesia was induced with propofol using syringe pump at 70 mgmin−1 until loss of verbal contact (LOVC) was achieved. The time to reach LOVC and the corresponding amount given were noted. Haemodynamic parameters were recorded at 60 s intervals for 5 minutes afterwards. Results: Midazolam pre-treatment significantly reduced the induction dose requirement of propofol and induction time (P < 0.0001). The incidence of adverse effects of propofol such as hypotension, apnoea and injection pain was significantly higher in the control group (P = 0.03). Conclusion: Midazolam pre-treatment effectively reduces both the induction dose of propofol and time of induction, as well as results in better haemodynamic stability and fewer adverse effects.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.